Krystal Biotech falls as data for pipeline programs pushed to 2027

Krystal Biotech stock fell after delaying pipeline data to 2027 despite a Q3 earnings beat. Read more here.

CryptoAlerta — análise de criptomoedas e mercado em tempo real